Human papillomaviruses and the genital tract: Old virus, new developments

References

1. de Villiers E.-M. Heterogeneity of the human papillomavirus group. J Virol 1989; 63:4898–4903
   [Google Scholar]
2. van Ranst M., Kaplan J. B., Burk R. D. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 1992; 73:2653–2660
   [Google Scholar]
3. Schneider A., Koutsky L. A. Natural history and epidemiological features of genital HPV infection. In Munoz N., Bosch F. X., Shah K. V., Meheus A. (eds) The epidemiology of cervical cancer and human papillomavirus (IARC Scientific Publication 119) Lyons: IARC; 199225–52
   [Google Scholar]
4. Meyers C., Frattini M. G., Hudson J. B., Laimins L. A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992; 257:971–973
   [Google Scholar]
5. Birley H. D. L., Kupek E., Byrne M., Whitaker L., Renton A. M. Clinical features and outcome of anogenital warts in men and women. J Eur Acad Dermatol Venereol 1994; 3:198–205
   [Google Scholar]
6. Rymark P., Forslund O., Hansson B. G., Lindholm K. Genital HPV infection not a local but a regional infection: experience from a female teenage group. Genitourin Med 1993; 69:18–22
   [Google Scholar]
7. Ferenczy A., Mitao M., Nagai N., Silverstein S. J., Crum C. P. Latent papillomavirus and recurring genital warts. N Engl J Med 1985; 313:784–788
   [Google Scholar]
8. Coleman N., Birley H. D. L., Renton A. M. Immunological events in regressing genital warts. Am J Clin Pathol 1994; 102:768–774
   [Google Scholar]
9. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991; 184:9–13
   [Google Scholar]
10. Inman G. J., Cook I. D., Lau R. K. W. Human papillomaviruses, tumour suppressor genes and cervical cancer. Int J STD AIDS 1993; 4:128–134
    [Google Scholar]
11. Banks L. A review of recent developments. Papillomavirus Report 1994; 5:187–189
    [Google Scholar]
12. Cromme F. V., Meijer C. J. L. M., Snijders P. J. F. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 1993; 67:1372–1380
    [Google Scholar]
13. Koutsky L. A., Holmes K. K., Critchlow C. W. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327:1272–1278
    [Google Scholar]
14. Munoz N., Bosch F. X. HPV and cervical neoplasia: review of case-control and cohort studies. In Munoz N., Bosch F. X., Shah K. V., Meheus A. (eds) The epidemiology of cervical cancer and human papillomavirus (IARC Scientific Publication 119) Lyons: IARC; 1992251–261
    [Google Scholar]
15. Bauer H. M., Greer C. E., Chambers J. C. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265:472–477
    [Google Scholar]
16. Mansell M. E., Ho L., Terry G., Singer A., Cuzick J. Semi quantitative human papillomavirus DNA detection in the management of women with minor cytological abnormality. Br J Obstet Gynaecol 1994; 101:807–809
    [Google Scholar]
17. Sherman M. E., Schiffman M. H., Lorincz A. T. Toward objective quality assurance in cervical cytopathology:correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994; 102:182–187
    [Google Scholar]
18. Bonnez W., Da Rin C., Rose R. C., Reichman R. C. Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata. J Gen Virol 1991; 72:1343–1347
    [Google Scholar]
19. Zhou J., Sun X. Y., Stenzel D. J., Frazer I. H. Expression of vaccinia recombinant HPV16 LI and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 1991; 185:251–257
    [Google Scholar]
20. Kirnbauer R., Hubbert N.L., Wheeler C. M., Becker T. M., Lowy D. R., Schiller J. T. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994; 86:494–498
    [Google Scholar]
21. Christensen N. D., Hopfl R., DiAngelo S. L. Assembled baculovirus-expressed human papillomavirus type 11 LI capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol 1994; 75:2271–2276
    [Google Scholar]
22. Brandsma J. L. Animal models for HPV vaccine development. Papillomavirus Report 1994; 5:105–111
    [Google Scholar]